Test could predict relapse chance - WALB.com, Albany News, Weather, Sports

Test could predict relapse chance

  • More WALB News10 HeadlinesMore News HeadlinesMore>>

  • Smack down on Cancer at the State Theater

    Smack down on Cancer at the State Theater

    Saturday, April 19 2014 11:54 PM EDT2014-04-20 03:54:50 GMT
    Wrestlers from all over Georgia and Florida were in town for the Smack Down on Cancer Event at the state theater. More >>
    Wrestlers from all over Georgia and Florida were in town for the Smack Down on Cancer Event at the state theater. More >>
  • Americus student honored in statewide design contest

    Americus student honored in statewide design contest

    Saturday, April 19 2014 7:59 PM EDT2014-04-19 23:59:05 GMT
    Indira Zelaya, a fourth grader from Sarah Cobb Elementary School in Americus, was honored in Atlanta recently for her artwork supporting Georgia's manufacturing industry.  She was nominated by South GeorgiaMore >>
    Indira Zelaya, a fourth grader from Sarah Cobb Elementary School in Americus, was honored in Atlanta recently for her artwork supporting Georgia's manufacturing industry.  She was nominated by South Georgia Technical College.More >>
  • Swimming pool destroyed after storm

    Swimming pool destroyed after storm

    Saturday, April 19 2014 7:32 PM EDT2014-04-19 23:32:11 GMT
    An Albany man arrived home to find his pool completely destroyed. He's not sure what happened, but the wall caved in and the concrete cracked. He says he's had the siding redone several times.More >>
    An Albany man arrived home to find his pool completely destroyed. He's not sure what happened, but the wall caved in and the concrete cracked. More >>

February 8, 2007

Albany - A new gene test for women who are in the early stages of breast cancer could predict if they will have a relapse. It's called the MammaPrint test.

The test could affect how aggressively those women will fight the initial tumor, and is 95% accurate if a woman is told she's at a low risk for relapse.

Dr. Jose Tongol, an oncologist at Phoebe's Cancer Center says genetic testing is commonplace and helps determine what type of treatment a patient needs. We are targeting cancer now.  He says, "Our treatment is targeted. We individualize to the person. If you come to me right now I do a lot of genetic marking testing for you. We have this one available at Phoebe and then we tell you the treatment for your genetic marking."

More than 178,000 U.S. women will be diagnosed with breast cancer this year. More than 100,000 will be in early stages and have a good prognosis because the tumors are small and haven't spread.

comments: news@walb.com?subject=GeneTestCancer

 

Powered by WorldNow